Malaria hemozoin: A target for point-of-care diagnosis.

Indian J Public Health

Senior Research Fellow, ICMR-National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh; Scientist B, ICMR-National Institute of Malaria Research, New Delhi, India.

Published: April 2023

The challenges in malaria diagnosis continue to threaten the malaria elimination goal in India and other malaria-endemic countries. A rapid diagnostic test (RDT) kit is widely used in resource-constrained areas where microscopy and molecular methods are not easily deployable. Considering the problems associated with the currently available RDT kit, such as histidine-rich protein 2 gene deletion and prolonged stability of the protein in the blood, it suggests that new potential biomarkers are urgently needed. Hemozoin (Hz) is an important biomarker for malaria diagnosis, which is the by-product of a detoxification mechanism in the malaria parasite. This article highlights the importance of "Hz" for point-of-care malaria diagnosis when India and other countries are moving toward the goal of malaria elimination.

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijph.ijph_1646_21DOI Listing

Publication Analysis

Top Keywords

malaria diagnosis
12
malaria elimination
8
rdt kit
8
malaria
7
malaria hemozoin
4
hemozoin target
4
target point-of-care
4
diagnosis
4
point-of-care diagnosis
4
diagnosis challenges
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!